The Dementia Discovery Fund
London, Englandtheddfund.com
Overview
The Dementia Discovery Fund (DDF), managed by SV Health Investors, is the world's largest family of specialized venture capital funds that invests exclusively in companies developing or enabling novel therapeutics for dementia . Dementias including Alzheimer's Disease are arguably the largest unmet medical need with over 55m patients worldwide . With more than $500m raised for this strategy, and offices in London and Boston, DDF capitalizes on global investment opportunities to fulfill its dual mandate of delivering measurable impact and generating significant financial returns .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Violet Therapeutics | May 2026 | Seed | Co-investor |
| Endlyz Therapeutics | May 2026 | Early Stage VC | Co-investor |
| Therini Bio | May 2025 | Series A Extension | Co-investor |
| Montara Therapeutics | Mar 2025 | Seed | Co-investor |
| Sudo Biosciences | Feb 2024 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.